AstraZeneca
1.444,5
SEK
-1,73 %
Mindre end 1K følgere
AZN
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
-1,73%
-10,94%
-0,14%
-0,14%
-10,03%
-0,55%
+16,4%
+63,63%
+7.804,02%
AstraZeneca is a global biopharmaceutical company that focuses on the research, development, and marketing of prescription drugs, primarily for the treatment of diseases in the areas of therapy that affect the respiratory tract, cardiovascular / metabolism, and cancer. In addition to its main operations, the company is also active in autoimmunity, neuroscience, and infection. AstraZeneca is active in all global regions and is headquartered in Cambridge.
Læs mereMarkedsværdi
2,24 bio. SEK
Aktieomsætning
640,49 mio. SEK
Omsætning
596,39 mia.
EBIT %
18,5 %
P/E
28,85
Udbytteafkast, %
2,37 %
Finanskalender
11.4
2025
Generalforsamling '25
29.4
2025
Delårsrapport Q1'25
Alle
Selskabsmeddelelser
ViserAlle indholdstyper
AstraZeneca: Final Results
AstraZeneca licenses lipid lowering Lp(a) asset
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools